Description:
<jats:title>Abstract</jats:title><jats:p>A heart transplant 62‐year‐old patient referred for coronavirus‐19 disease (COVID‐19) pneumonia. At admission, he was febrile, tachypnoeic, and mild hypoxic with dry cough; during hospitalization, a diffuse morbilliform skin rash appeared. He was treated with tocilizumab with symptoms improvement, without a complete pulmonary function recovery. Skin rash, highly suggestive for COVID‐19 cutaneous involvement, persisted for ten days despite tocilizumab administration.</jats:p>